Triple-drug chemotherapy regimens in combination with an anti-EGFR agent in metastatic colorectal cancer - prospects from phase II clinical trials

  1. Matos, I.
  2. Noguerido, A.
  3. Ros, J.
  4. Mulet, N.
  5. Argilés, G.
  6. Elez, É.
  7. Tabernero, J.
Revue:
Expert Opinion on Investigational Drugs

ISSN: 1744-7658,  1354-3784

Année de publication: 2019

Volumen: 28

Número: 5

Pages: 463-471

Type: Article

DOI: 10.1080/13543784.2019.1599860 GOOGLE SCHOLAR
La source de données: Scopus